Skip to main content

Table 3 General characteristics of study participants1

From: The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder

 

Matrix group (n = 20)

Methylphenidate group (n = 22)

Matrix combination with methylphenidate group (n = 21)

Control group (n = 22)

P2

Age (y)

30.7 ± 6.1

31.8 ± 5.6

29.4 ± 2.7

31.0 ± 2.7

0.39

Education status (%)

 Elementary

5 (25)

9 (40.9)

8 (38.1)

7 (31.8)

 

 Intermediate

8 (40)

4 (18.3)

3 (14.3)

7 (31.8)

 

 Diploma

5 (25)

6 (27.3)

8 (38.1)

5 (22.7)

0.52†

 College

0 (0)

3 (13.6)

1 (4.8)

1 (4.5)

 

 Bachelor of science (BSc)

2 (10)

0 (0)

1 (4.8)

2 (9.1)

 

Marital status (%)

 Permanent marriage

8 (40)

3 (13.6)

6 (28.6)

8 (36.4)

 

 Single

6 (30)

11 (50)

6 (28.6)

7 (31.8)

0.49††

 Widow/Divorced

6 (30)

8 (36.4)

9 (42.9)

7 (31.8)

 

Job (%)

 Unemployed

12 (60)

14 (63..6)

7 (33.3)

8 (36.4)

 

 Employed

2 (10)

1 (4.5)

2 (9.5)

0 (0)

0.09†

 Others

6 (30)

7 (31.8)

12 (57.1)

14 (63.6)

 

Methadone dose (mL/d)

16.8 ± 4.4

18.6 ± 5.3

18.1 ± 5.7

18.0 ± 3.7

0.67

Duration of MMT (y)

4.7 ± 2.3

4.1 ± 2.0

5.4 ± 2.1

4.1 ± 1.9

0.16

Dose of METH use (g/week)

0.35 ± 0.2

0.43 ± 0.2

0.35 ± 0.2

0.43 ± 0.2

0.55

Frequency of METH use (week)

2.9 ± 1.6

3.7 ± 2.0

3.4 ± 1.8

3.4 ± 1.7

0.53

Duration of METH use (y)

1.8 ± 0.83

2.1 ± 0.94

1.7 ± 0.76

2.3 ± 0.94

0.12

  1. 1 Data are mean ± SDs
  2. 2 Obtained from One-Way ANOVA
  3. † Obtained from Fisher’s Exact test
  4. †† Obtained from Pearson Chi-square test